Contact this trialFirst, we need to learn more about you.
ADX-914 for Atopic Dermatitis
Recruiting0 awardsPhase 2
Seattle, Washington
This trial is testing a new drug called ADX-914 in adults with moderate to severe Atopic Dermatitis. The drug is given as an injection over a period of a few months. It aims to reduce skin inflammation and improve skin condition.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.